Research ArticleOriginal Article
Open Access

Clinical and biochemical profile of Guillain Barré Syndrome in Pakistan

Rashid Iqbal, Muhammad J. Asad, Muhammad B. Shah, Raja T. Mahmood and Saima Siddiqi
Neurosciences Journal July 2021, 26 (3) 242-247; DOI: https://doi.org/10.17712/nsj.2021.3.20200178

References

  1. 1.↵
    1. Teo E,
    2. Azwra A,
    3. Jones R,
    4. Gazzard BG,
    5. Nelson M.
    Guillain-Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Ther 2007; 12: 62–63.
    OpenUrlPubMed
  2. 2.↵
    1. Yuki N,
    2. Hartung H-P.
    Guillain–Barré syndrome. N Engl J Med 2012; 366: 2294–2304.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Shang P,
    2. Zhu M,
    3. Wang Y,
    4. Zheng X,
    5. Wu X,
    6. Zhu J, et al.
    Axonal variants of Guillain–Barré syndrome: an update. J Neurol 2020: 1–18.
  4. 4.↵
    1. Debnath M,
    2. Nagappa M,
    3. Murari G,
    4. Taly AB.
    IL-23/IL-17 immune axis in Guillain Barre syndrome: exploring newer vistas for understanding pathobiology and therapeutic implications. Cytokine 2018; 103: 77–82.
    OpenUrl
  5. 5.↵
    1. Wu X,
    2. Wang J,
    3. Liu K,
    4. Zhu J,
    5. Zhang H-L.
    Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome? Expert Opin Ther Targets 2016; 20: 209–222.
    OpenUrl
  6. 6.↵
    1. Wang Z,
    2. Zhang J,
    3. Mi J,
    4. Ma H,
    5. Zhao D.
    Expression and significance of interleukin-17 and interleukin-22 in the serum and the lower esophageal sphincter of patients with achalasia. Saudi J Gastroenterol 2018; 24: 242–248.
    OpenUrl
  7. 7.↵
    1. Berciano J,
    2. Orizaola P,
    3. Gallardo E,
    4. Pelayo-Negro AL,
    5. Sánchez-Juan P,
    6. Infante J, et al.
    Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study. Clin Neurophysiol Pract 2019; 5: 1–9.
    OpenUrl
  8. 8.↵
    1. Zeppelin Z,
    2. Kristensen S,
    3. Fuglsang-Frederiksen A,
    4. Andersen H,
    5. Harbo L,
    6. Levison L, et al.
    P85-F The utility of MVRCs in detection of early axonal involvement in GBS. Clinical Neurophysiology 2019; 130: e92.
    OpenUrl
  9. 9.↵
    1. Tunç A.
    Early predictors of functional disability in Guillain–Barré Syndrome. Acta Neurol Belg 2019; 119: 555–559.
    OpenUrl
  10. 10.↵
    1. Van Koningsveld R,
    2. Steyerberg EW,
    3. Hughes RA,
    4. Swan AV,
    5. van Doorn PA,
    6. Jacobs BC.
    A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol 2007; 6: 589–594.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Roth S,
    2. Spalinger MR,
    3. Gottier C,
    4. Biedermann L,
    5. Zeitz J,
    6. Lang S, et al.
    Bilberry-derived anthocyanins modulate cytokine expression in the intestine of patients with ulcerative colitis. PLoS One 2016; 11: e0154817.
    OpenUrl
  12. 12.↵
    1. Li S,
    2. Yu M,
    3. Li H,
    4. Zhang H,
    5. Jiang Y.
    IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome. Mediators Inflamm 2012; 2012: 260473..
    OpenUrlPubMed
  13. 13.↵
    1. Maleb A,
    2. Bouayadi O,
    3. El Malki J,
    4. Rifai S,
    5. Lamrabat S,
    6. Benaissa E, et al.
    Cytological examination of cerebrospinal fluid: Sysmex UF-1000i versus optical microscopy. Anal Biochem 2020; 589: 113501.
    OpenUrl
  14. 14.↵
    1. Kalra V,
    2. Chaudhry R,
    3. Dua T,
    4. Dhawan B,
    5. Sahu JK,
    6. Mridula B.
    Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study. J Child Neurol 2009; 24: 664–668.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Zia MA,
    2. Masood Y,
    3. Salman MK.
    Guillain-barré syndrome; autonomic disturbances in children. Professional Medical J 2018; 25: 538–544.
    OpenUrl
  16. 16.↵
    1. Lu M-O,
    2. Zhu J.
    The role of cytokines in Guillain–Barré syndrome. J Neurol 2011; 258: 533–548.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Akbayram S,
    2. Doğan M,
    3. Akgün C,
    4. Peker E,
    5. Sayin R,
    6. Aktar F, et al.
    Clinical features and prognosis with Guillain-Barré syndrome. Ann Indian Acad Neurol 2011; 14: 98–102.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Brettschneider J,
    2. Petzold A,
    3. Süssmuth S,
    4. Tumani H.
    Cerebrospinal fluid biomarkers in Guillain-Barré syndrome–Where do we stand? J Neurol 2009; 256: 3–12.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Nomani AZ,
    2. Iqbal M,
    3. Majeed H,
    4. Badshah M,
    5. Nabi S,
    6. Jan Z, et al.
    Albuminocytological dissociation in different electrophysiological gbs variants. Pak J of Neurological Sciences 2015; 10: 32–36.
    OpenUrl
  20. 20.↵
    1. Cetiner M,
    2. Seyit M,
    3. Akdağ G,
    4. Demirbaş H,
    5. Temel Ö,
    6. Kabay SC.
    Factors Associated with Prognosis in Patients with Guillain-Barré Syndrome. Turk J of Neurol 2019; 25: 140–145.
    OpenUrl
  21. 21.↵
    1. Shafqat S,
    2. Khealani B,
    3. Awan F,
    4. Abedin S.
    Guillain–Barré syndrome in Pakistan: similarity of demyelinating and axonal variants. Eur J Neurol 2006; 13: 662–665.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Kalita J,
    2. Misra U,
    3. Das M.
    Neurophysiological criteria in the diagnosis of different clinical types of Guillain–Barre syndrome. J Neurol Neurosurg Psychiatry 2008; 79: 289–293.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Debnath B,
    2. Hussain ME,
    3. Haque N,
    4. Khan AAM,
    5. Mian MF,
    6. Islam MN, et al.
    Clinical and ElectrophysiologicAspects of Guillain Barre Syndrome among Children: Experience at Referral Tertiary Care Hospital in Bangladesh. Journal of National Institute of Neurosciences Bangladesh 2019; 5: 2–7.
    OpenUrl
  24. 24.↵
    1. Yakoob MY,
    2. Rahman A,
    3. Jamil B,
    4. Syed NA.
    Characteristics of patients with Guillain Barre Syndrome at a tertiary care centre in Pakistan, 1995-2003. J Pak Med Assoc 2005; 55: 493–496.
    OpenUrlPubMed
  25. 25.↵
    1. Zhang B,
    2. Wu X,
    3. Shen D,
    4. Li T,
    5. Li C,
    6. Mao M, et al.
    The clinical characteristics and short-term prognosis in elderly patients with Guillain–Barré syndrome. Medicine (Baltimore) 2017; 96: e5848.
    OpenUrl
  26. 26.↵
    1. Webb AJ,
    2. Brain SA,
    3. Wood R,
    4. Rinaldi S,
    5. Turner MR.
    Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry 2015; 86: 1196–1201.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section